OTTAWA—Canada’s current system of controlling drug prices helps contain spending but more aggressive measures are needed, says a new study released today by the Canadian Centre for Policy Alternatives.
The study, by Dr. Joel Lexchin, finds evidence to support the contention that increasing the amount of public spending on medications will help to control overall drug expenditures....
Over the last 30 years, the CCPA has provided alternative research and analysis that have been indispensable in exposing the corporate agenda. I don’t know what I’d have done without them.